Literature DB >> 11090174

Wide range of viral load in healthy african green monkeys naturally infected with simian immunodeficiency virus.

S Goldstein1, I Ourmanov, C R Brown, B E Beer, W R Elkins, R Plishka, A Buckler-White, V M Hirsch.   

Abstract

The distribution and levels of simian immunodeficiency virus (SIV) in tissues and plasma were assessed in naturally infected African green monkeys (AGM) of the vervet subspecies (Chlorocebus pygerythrus) by limiting-dilution coculture, quantitative PCR for viral DNA and RNA, and in situ hybridization for SIV expression in tissues. A wide range of SIV RNA levels in plasma was observed among these animals (<1,000 to 800,000 copies per ml), and the levels appeared to be stable over long periods of time. The relative numbers of SIV-expressing cells in tissues of two monkeys correlated with the extent of plasma viremia. SIV expression was observed in lymphoid tissues and was not associated with immunopathology. Virus-expressing cells were observed in the lamina propria and lymphoid tissue of the gastrointestinal tract, as well as within alveolar macrophages in the lung tissue of one AGM. The range of plasma viremia in naturally infected AGM was greater than that reported in naturally infected sooty mangabeys. However, the degree of viremia in some AGM was similar to that observed during progression to AIDS in human immunodeficiency virus-infected individuals. Therefore, containment of viremia is an unlikely explanation for the lack of pathogenicity of SIVagm in its natural host species, AGM.

Entities:  

Mesh:

Year:  2000        PMID: 11090174      PMCID: PMC112457          DOI: 10.1128/jvi.74.24.11744-11753.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

Review 1.  Immunopathogenesis of SIVmac.

Authors:  M A Simon; S J Brodie; V G Sasseville; L V Chalifoux; R C Desrosiers; D J Ringler
Journal:  Virus Res       Date:  1994-05       Impact factor: 3.303

Review 2.  Pathogenic diversity of simian immunodeficiency viruses.

Authors:  V M Hirsch; P R Johnson
Journal:  Virus Res       Date:  1994-05       Impact factor: 3.303

3.  Studies in subjects with long-term nonprogressive human immunodeficiency virus infection.

Authors:  G Pantaleo; S Menzo; M Vaccarezza; C Graziosi; O J Cohen; J F Demarest; D Montefiori; J M Orenstein; C Fox; L K Schrager
Journal:  N Engl J Med       Date:  1995-01-26       Impact factor: 91.245

4.  Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection.

Authors:  Y Cao; L Qin; L Zhang; J Safrit; D D Ho
Journal:  N Engl J Med       Date:  1995-01-26       Impact factor: 91.245

5.  Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.

Authors:  R A Koup; J T Safrit; Y Cao; C A Andrews; G McLeod; W Borkowsky; C Farthing; D D Ho
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

6.  High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR.

Authors:  M Piatak; M S Saag; L C Yang; S J Clark; J C Kappes; K C Luk; B H Hahn; G M Shaw; J D Lifson
Journal:  Science       Date:  1993-03-19       Impact factor: 47.728

7.  HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease.

Authors:  G Pantaleo; C Graziosi; J F Demarest; L Butini; M Montroni; C H Fox; J M Orenstein; D P Kotler; A S Fauci
Journal:  Nature       Date:  1993-03-25       Impact factor: 49.962

8.  Induction of AIDS by simian immunodeficiency virus from an African green monkey: species-specific variation in pathogenicity correlates with the extent of in vivo replication.

Authors:  V M Hirsch; G Dapolito; P R Johnson; W R Elkins; W T London; R J Montali; S Goldstein; C Brown
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

9.  Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques.

Authors:  K A Reimann; K Tenner-Racz; P Racz; D C Montefiori; Y Yasutomi; W Lin; B J Ransil; N L Letvin
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

10.  Mosaic genome structure of simian immunodeficiency virus from west African green monkeys.

Authors:  M J Jin; H Hui; D L Robertson; M C Müller; F Barré-Sinoussi; V M Hirsch; J S Allan; G M Shaw; P M Sharp; B H Hahn
Journal:  EMBO J       Date:  1994-06-15       Impact factor: 11.598

View more
  50 in total

1.  Epidemiology, genetic diversity, and evolution of endemic feline immunodeficiency virus in a population of wild cougars.

Authors:  Roman Biek; Allen G Rodrigo; David Holley; Alexei Drummond; Charles R Anderson; Howard A Ross; Mary Poss
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

2.  The well-tempered SIV infection: Pathogenesis of SIV infection in natural hosts in the wild, with emphasis on virus transmission and early events post-infection that may contribute to protection from disease progression.

Authors:  Kevin Raehtz; Ivona Pandrea; Cristian Apetrei
Journal:  Infect Genet Evol       Date:  2016-07-06       Impact factor: 3.342

Review 3.  On the relative fitness of early and late stage Simian immunodeficiency virus isolates.

Authors:  Dominik Wodarz
Journal:  Theor Popul Biol       Date:  2007-03-21       Impact factor: 1.570

4.  High levels of viral replication contrast with only transient changes in CD4(+) and CD8(+) cell numbers during the early phase of experimental infection with simian immunodeficiency virus SIVmnd-1 in Mandrillus sphinx.

Authors:  Richard Onanga; Christopher Kornfeld; Ivona Pandrea; Jerome Estaquier; Sandrine Souquière; Pierre Rouquet; Virginie Poaty Mavoungou; Olivier Bourry; Souleymane M'Boup; Françoise Barré-Sinoussi; François Simon; Cristian Apetrei; Pierre Roques; Michaela C Müller-Trutwin
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

5.  Simian immunodeficiency virus (SIV)-specific CD8+ T-cell responses in vervet African green monkeys chronically infected with SIVagm.

Authors:  Roland C Zahn; Melisa D Rett; Birgit Korioth-Schmitz; Yue Sun; Adam P Buzby; Simoy Goldstein; Charles R Brown; Russell A Byrum; Gordon J Freeman; Norman L Letvin; Vanessa M Hirsch; Jörn E Schmitz
Journal:  J Virol       Date:  2008-10-01       Impact factor: 5.103

6.  Primary simian immunodeficiency virus SIVmnd-2 infection in mandrills (Mandrillus sphinx).

Authors:  Richard Onanga; Sandrine Souquière; Maria Makuwa; Augustin Mouinga-Ondeme; François Simon; Cristian Apetrei; Pierre Roques
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

7.  Early divergence in neutrophil apoptosis between pathogenic and nonpathogenic simian immunodeficiency virus infections of nonhuman primates.

Authors:  Carole Elbim; Valerie Monceaux; Yvonne M Mueller; Mark G Lewis; Stephanie François; Ousmane Diop; Khadija Akarid; Bruno Hurtrel; Marie-Anne Gougerot-Pocidalo; Yves Lévy; Peter D Katsikis; Jerome Estaquier
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

Review 8.  Into the wild: simian immunodeficiency virus (SIV) infection in natural hosts.

Authors:  Ivona Pandrea; Donald L Sodora; Guido Silvestri; Cristian Apetrei
Journal:  Trends Immunol       Date:  2008-09       Impact factor: 16.687

9.  CD4 downregulation by memory CD4+ T cells in vivo renders African green monkeys resistant to progressive SIVagm infection.

Authors:  Coreen M Beaumier; Levelle D Harris; Simoy Goldstein; Nichole R Klatt; Sonya Whitted; John McGinty; Cristian Apetrei; Ivona Pandrea; Vanessa M Hirsch; Jason M Brenchley
Journal:  Nat Med       Date:  2009-06-14       Impact factor: 53.440

10.  Inhibition of adaptive immune responses leads to a fatal clinical outcome in SIV-infected pigtailed macaques but not vervet African green monkeys.

Authors:  Jörn E Schmitz; Roland C Zahn; Charles R Brown; Melisa D Rett; Ming Li; Haili Tang; Sarah Pryputniewicz; Russell A Byrum; Amitinder Kaur; David C Montefiori; Jonathan S Allan; Simoy Goldstein; Vanessa M Hirsch
Journal:  PLoS Pathog       Date:  2009-12-11       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.